Trial Profile
Randomized Phase 2 trial of Individualized Monotherapy based on CYFRA-21-1 serum levels before treatment Versus Pemetrexed Monotherapy in Older Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer and wild-type EGFR tumors
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Pemetrexed (Primary) ; Docetaxel; Gemcitabine
- Indications Non-small cell lung cancer
- Focus Biomarker; Therapeutic Use
- 25 Nov 2013 New trial record